Rosemary A. Fryer

Recent advances and developments in treatment strategies against pancreatic cancer.

A. Dalgleish, C. Galustian, R. A. Fryer, 2009, Current clinical pharmacology.

Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma

N. Potter, S. H. Wilson, G. Vijayaraghavan, 2014, Leukemia.

Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide.

A. Dalgleish, C. Galustian, Angus G Dalgleish, 2011, Anticancer research.

Hsp70 inhibition induces myeloma cell death via the intracellular accumulation of immunoglobulin and the generation of proteotoxic stress☆

G. Morgan, P. Workman, F. Davies, 2013, Cancer letters.